Essential Drugs Monitor No. 032 (2003)
(2003; 48 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentEDITORIAL - 25 years of essential medicines progress
Afficher le documentANNIVERSARY ISSUE - Improving drug regulation
Afficher le documentDrug pricing survey in KwaZulu-Natal
Afficher le documentReducing costs through regional pooled procurement
Afficher le documentDispensing prescribers - a threat to appropriate medicines use?
Afficher le documentDrug and therapeutics committees: vehicles for improving rational drug use
Afficher le documentAnnouncing ICIUM 2004
Afficher le documentAccess to essential medicines: a global necessity
Afficher le documentMemories of the First Expert Committee Meeting and celebrating 25 years later
Afficher le document25 years of essential medicines: events around the world
Afficher le documentPersonal reflections on 25 years of the WHO Model List of Essential Medicines
Afficher le documentDrug utilization in Latin America - the example of DURG-LA
Afficher le documentGlobal TB Drug Facility: improving access to TB drugs
Afficher le documentDemystifying antiretroviral therapy in resource-poor settings
Afficher le documentCBIA: improving the quality of self-medication through mothers’ active learning
Afficher le documentIndian hospital drug use study shows need to improve prescribing
Afficher le documentWHO’s new Model Formulary - promoting consumer rights and patient safety
 

Essential Drugs Monitor No. 032 (2003)


WORLD HEALTH ORGANIZATION

Essential Drugs Monitor

The Essential Drugs Monitor is produced and distributed by the WHO Department of Essential Drugs and Medicines Policy (EDM). It is published in Chinese, English, French, Spanish and Russian, and has a global readership of some 300,000 to whom it is free of charge. The Monitor carries news of developments in national drug policies, therapeutic guidelines, current pharmaceutical issues, educational strategies and operational research.

WHO’s Department of Essential Drugs and Medicines Policy seeks to ensure that all people - wherever they may be - are able to obtain the drugs they need at a price that they and their country can afford; that these drugs are safe, effective and of good quality; and that they are prescribed and used rationally.

All correspondence should be addressed to:

The Editor
Essential Drugs Monitor
World Health Organization
CH-1211 Geneva 27, Switzerland
Fax: +41 22-791-4167
e-mail: medmail@who.int

 

vers la section suivante
 

Dernière mise à jour: le 3 mai 2013